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Boaz D. Rosen, MD,yz João A.C. Lima, MDySEE PAGE 540M easurements of cardiac output by indica-tor or thermodilution techniques wereamong the ﬁrst methods developed to
assess cardiac function (1). It is clear, however, that
even when normalized for body size, cardiac output
measured at rest is limited as a clinical measure
because the heart is designed to support vast demand
variations during daily life. Except for critical care sit-
uations in which cardiac output is useful as a clinical
parameter, the most used index of cardiac perfor-
mance is left ventricular ejection fraction (LVEF).
LVEF has proved to be a reliable parameter to the
clinician contemplating the prognosis and manage-
ment of patients with heart disease (e.g., in selecting
patients for implantable cardioverter-deﬁbrillators).
Over the past several decades, it has become estab-
lished that performance measurements at different
loading conditions or oxygen demand are preferable
to those obtained at rest (2). However, the simplicity
of parameters such as LVEF have proved to be sufﬁ-
cient for most clinical needs.
As part of the efforts to quantify cardiac function,
several techniques to assess regional myocardial
deformation have been developed, based primarily
on the measurement of myocardial strain along
different orientations. Over the past 2 decades,
myocardial tagging (3,4) substituted invasive me-
thods of measuring myocardial deformation and
ushered in an era of unprecedented progress in our
understanding of myocardial function (5,6). Tissue*Editorials published in JACC: Cardiovascular Imaging reﬂect the views of
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contents of this paper to disclose.Doppler and speckle tracking techniques have
extended the ability to assess myocardial segmental
deformation in systole and diastole on ultrasound (7),
creating the possibility of even wider clinical utiliza-
tion. Although LVEF is load dependent, such depen-
dence appears to be less for shortening measured
along normal orientations such as circumferential
and longitudinal. However, although cardiac mag-
netic resonance (CMR) tagging has been used as a
clinical research tool and in population studies, its
prognostic potential in clinical settings has not been
established.In this issue of iJACC, Mordi et al. (8) present data
supporting the application of circumferential short-
ening measured by CMR tagging to assess prognosis in
539 patients with suspected heart disease referred for
CMR. A comprehensive assessment of cardiac global
structure and function, myocardial global circumfer-
ential strain (GCS), and myocardial ﬁbrosis by late
gadolinium enhancement (LGE) were performed. The
authors examined whether such parameters improved
the power of detecting the primary endpoint, the
prevalence of major adverse cardiovascular events,
which included a combination of all-cause mortality,
heart failure–related hospitalization, and aborted
sudden cardiac death. Two-thirds of the patients were
male, and the cohort was relatively young (mean
age 48.1 years). Indications for CMR included assess-
ment of nonischemic (36.9%) or ischemic (19.9%)
cardiomyopathy, ventricular arrhythmia (13.9%),
suspected myocarditis (11.9%), or LV hypertrophy
(10.9%). Overall, 11.5% (62 of 539) of the enrolled pa-
tients developed the primary endpoint over a mean
duration of follow-up of 2.2 years. On multivariate
analysis, ischemic heart disease, LVEF <35%, and the
presence of myocardial ﬁbrosis by LGE were pre-
dictors of untoward outcomes. Reduced GCS as
measured was also a strong predictor of an
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551unfavorable prognosis. The combination of ﬁbrosis by
LGE with reduced GCS in patients with LVEF $35%
was prognostically similar to that in patients with
LVEF <35%.
The authors performed CMR tagging using com-
mercial software now available for all major CMR
vendors and analyzed the data using harmonic phase
imaging, a method developed and validated a decade
ago (9) and that has been applied to clinical and large-
scale population studies (10,11). This is the ﬁrst study
establishing the prognostic signiﬁcance of reduced
GCS in a large-scale cohort of patients being investi-
gated for cardiac structural and functional impair-
ment. GCS across the left ventricle can be easily
analyzed by CMR. Large datasets with reference
values (12) exist for this technique, including that in
the present study (8). The results of the present
study, as well as those from previous studies using
CMR tagging (6) and echocardiography (7), suggest
that regional function deﬁned by strain may be more
sensitive than ejection fraction in the detection of
incipient myocardial dysfunction.
The authors utilized standard statistical method-
ology to assess the incremental prognostic value of
distinct CMR parameters added to clinical indicators.
They also used a combined model to evaluate the
added value of speciﬁc CMR indices over and above
other CMR parameters, as demonstrated in Table 6
(8). For that analysis, each parameter was classiﬁed as
normal or abnormal as deﬁned from cutoff points
obtained from a receiver-operating characteristic
curve. The areas under the curve were 0.834 for
LVEF, 0.699 for LGE, and 0.820 for GCS. Some would
want to see the additional power of indexes measured
as increments to the areas under the curve of base
models, which are more powerful than chi-square
analysis and are a higher benchmark for incremental
prognostic power (13). Others would want to see the
power to reclassify patients using net reclassiﬁcation
index or integrated discrimination improvement as
further evidence of the utility of this marker.
In a subgroup analysis, the authors demonstrate
that the presence of myocardial ﬁbrosis by LGEand/or myocardial dysfunction by reduced circum-
ferential strain identiﬁed patients who were at higher
risk for adverse outcomes despite having LVEF $35%.
It is suggested that LGE and reduced circumferential
strain may be particularly signiﬁcant for detecting
higher risk for malignant arrhythmias because 11 of 35
patients with the primary outcome in that group died
and an additional 10 patients had aborted sudden
cardiac death. Since the ﬁrst study reporting on the
prognostic power of myocardial ﬁbrosis detected
as delayed enhancement in post-infarct patients,
several studies have established that association in
different patient groups (14–16). The present study is
unique for its assessment of this association in a
large-scale cohort of patients with LVEF $35%
(n ¼ 474). Yet, it would be important to assess the
prognostic value of GCS and LGE in different sub-
groups (including those with ischemic heart disease,
dilated cardiomyopathy, or amyloidosis). The only
subgroup that was tested was that with nonischemic
cardiomyopathy.
Finally, it is worth mentioning that data accumu-
lated from other studies, in particular the Multi-
Ethnic Study on Atherosclerosis, appear to support
the authors’ hypothesis that alterations of GCS may
reﬂect myocardial ﬁbrosis. Established risk factors for
diffuse myocardial ﬁbrosis, such as aging (5), LV hy-
pertrophy (11), and atherosclerosis (17), are associated
with decreased regional and global circumferential
strain. Similar to the ﬁndings described by Mordi
et al. (8), among the participants in the Multi-Ethnic
Study on Atherosclerosis who were healthy at study
entry, strain deﬁcits predicted prognosis over and
above LVEF (6). The current study is a crucial step
toward bringing such knowledge to application where
it matters most, that is, patients with suspected heart
disease.
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